Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart
Authors:
Open Access
- 18 October 2012
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 107 (6) , 1-14
Abstract
The strategy to reprogram somatic stem cells to pluripotency status has provided an alternative source of surrogate ES cells (ESC). We report efficient reprogramming of multipotent bone marrow (BM) mesenchymal stem cells (MSC) to pluripotent status and the resultant MSC derived iPS cells (MiPS) and their derived progenitors effectively repaired the infarcted heart. MSC from young, male, Oct4-GFP transgenic mice were reprogrammed by retroviral transduction with Oct4, Sox2, Klf4, and c-Myc stemness factors. MiPS thus generated displayed characteristics of mouse ESC including morphology, surface antigens, gene and miR expression profiles. MiPS also formed spontaneously beating cardiac progenitors which expressed cardiac specific transcription factors and protein markers including Gata4, Mef2c, Nkx2.5, myosin heavy chain, troponin-I, and troponin-T, and showed ultra structural characteristics typical of cardiomyocytes. Intramyocardial delivery of MiPS (group-2) and their derivative cardiac-like cells (MiPS-CP; group-3) in a mouse model of acute myocardial infarction showed extensive survival and engraftment at 4 weeks with resultant attenuation of infarct size (p < 0.001 vs. DMEM injected control; n = 4). Engraftment of MiPS-CP was without cardiac tumorigenesis as compared to 21 % in MiPS transplanted animals. Furthermore, angiogenesis was improved in groups-2 and 3 (p < 0.001 vs. control). Transthoracic echocardiography revealed significantly preserved indices of cardiac contractility (ejection fraction p < 0.001 and fractional shortening p < 0.001 vs. control; n = 7). MSC were successfully reprogrammed into MiPS that displayed ESC-like characteristics and differentiated into spontaneously beating cardiomyocytes. Cardiac progenitors derived from MiPS repopulated the infarcted heart without tumorigenesis and improved global cardiac function.Keywords
This publication has 42 references indexed in Scilit:
- Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyondBasic Research in Cardiology, 2011
- Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammationBasic Research in Cardiology, 2011
- Control of cardiovascular differentiation by microRNAsBasic Research in Cardiology, 2010
- Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem CellsCirculation, 2009
- Variation in the safety of induced pluripotent stem cell linesNature Biotechnology, 2009
- MicroRNAs: key regulators of stem cellsNature Reviews Molecular Cell Biology, 2009
- A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem CellsCell Stem Cell, 2008
- Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125bJournal of Biological Chemistry, 2007
- Supportive Interaction Between Cell Survival Signaling and Angiocompetent Factors Enhances Donor Cell Survival and Promotes Angiomyogenesis for Cardiac RepairCirculation Research, 2006
- Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarctsNature, 2004